| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Possible Bearish Inside Day Candle Pattern Detected for Vermillion | | 1 | SmarTrend |
| 24.05.
| Stock to Watch: Vermillion Up 15.8% | | 7 | SmarTrend |
| 15.05.
| Vermillion Announces CEO Succession Plan | | 35 | PR Newswire |
| AUSTIN, Texas, May 15, 2012 /PRNewswire/ --The board of directors of Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has begun the process of identifying a successor to Gail...
Mehr lesen zu:
Vermillion Announces CEO Succession Plan | |
| 15.05.
| Vermillion Reports First Quarter 2012 Results | | 25 | PR Newswire |
| AUSTIN, Texas, May 15, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31...
Mehr lesen zu:
Vermillion Reports First Quarter 2012 Results | |
| 09.05.
| Vermillion to Present at B. Riley & Co. 13th Annual Investor Conference on May 23, 2012 | | 23 | PR Newswire |
| AUSTIN, Texas, May 9, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has been invited to present at the B. Riley & Co. 13th Annual Investor Conference....
Mehr lesen zu:
Vermillion to Present at B. Riley & Co. 13th Annual Investor Conference on May 23, 2012 | |
| 08.05.
| Stock to Watch: Vermillion Up 6.5% | | 2 | SmarTrend |
| 08.05.
| Vermillion (VRML) Shares on the Move as Co. Gets Patent for Platelet Biomarkers for Cancer | | - | StreetInsider.com |
| 30.04.
| Vermillion Resolves Non-Contingent Claims with Bio-Rad; Vermillion to be Returned More Than $1M from Escrow | | 1 | Benzinga.com |
| 30.04.
| Vermillion Resolves Non-Contingent Claims with Bio-Rad | | 8 | PR Newswire |
| AUSTIN, Texas, April30, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ:VRML), a leading molecular diagnostics company, has resolved all four of the non-contingent contract claims with Bio-Rad Laboratories...
Mehr lesen zu:
Vermillion Resolves Non-Contingent Claims with Bio-Rad | |
| 27.04.
| VERMILLION, INC. - 10-K/A, Annual Report | | 1 | SEC Filings |
| 27.04.
| Vermillion Board of Directors Unanimously Nominates Paul R. Sohmer, M.D. for Company Director | | 34 | PR Newswire |
| AUSTIN, Texas, April 27, 2012 /PRNewswire/ --Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, announces that its board of directors has unanimously nominated Paul R. Sohmer...
Mehr lesen zu:
Vermillion Board of Directors Unanimously Nominates Paul R. Sohmer, M.D. for Company Director | |
| 24.04.
| Stock to Watch: Vermillion Up 11.4% | | 2 | SmarTrend |
| 24.04.
| Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET | | 9 | PR Newswire |
| AUSTIN, Texas, April 24, 2012 /PRNewswire/ --Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, will hold a conference call on Tuesday, May 15, 2012 at 4:30 p.m....
Mehr lesen zu:
Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET | |
| 16.04.
| Vermillion (VRML) Gets Patent for Ovarian Cancer Biomarkers | | 1 | StreetInsider.com |
| 16.04.
| Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer | | 17 | PR Newswire |
| AUSTIN, Texas, April 16, 2012 /PRNewswire/ --Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has received a notice of allowance from the United States Patent and Trademark...
Mehr lesen zu:
Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer | |
| 09.04.
| Relatively Low Revenue Per Employee Detected in Shares of Vermillion in the Health Care Equipment Industry | | 3 | SmarTrend |
| 28.03.
| Vermillion gets US patent on cancer test methods | | 2 | Reuters.com |
| 28.03.
| Vermillion (VRML) Gets New Biomarket Patent for Ovarian Cancer | | - | StreetInsider.com |
| 28.03.
| Vermillion Receives Notice of Allowance for Patent on Methods for Diagnosing Ovarian Cancer | | 12 | PR Newswire |
| AUSTIN, Texas, March 28, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, has received a notice of allowance from the United States Patent...
Mehr lesen zu:
Vermillion Receives Notice of Allowance for Patent on Methods for Diagnosing Ovarian Cancer | |
| 27.03.
| Vermillion Reports Fourth Quarter and Full Year 2011 Results | | 57 | PR Newswire |
| AUSTIN, Texas, March 27, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, reported financial and operational results for the fourth quarter and full year...
Mehr lesen zu:
Vermillion Reports Fourth Quarter and Full Year 2011 Results | |
